ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.351,79
0,65%
S&P 500
5.116,17
0,32%
US Dollar vs BRL
5,1183
0,00%
Bitcoin
61.636,36
-3,46%
Brent Oil
87,525
0,27%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Gilead Sciences Inc (GILD)

  7. Gilead Sciences Inc (GILD) Notícias

GILD Gilead Sciences Inc

65,94
0,00 (0,00%)
Pré-mercado
Última atualização: 07:33:51
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Gilead Sciences Inc GILD NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,00 0,00% 65,94 07:33:51
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
65,94
mais cotações »

Notícias Recentes

Data Hora Fonte Título
26/04/202409:00BWFDA Approves Biktarvy® Label Update With Data for Pregnant..
26/04/202408:47IHMARKETNEWSExxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian..
25/04/202417:02BWGilead Sciences Announces First Quarter 2024 Financial..
25/04/202408:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
08/04/202417:05BWGilead Sciences to Release First Quarter 2024 Financial..
28/03/202409:30BWFDA Expands Indication for Gilead's Vemlidy (Tenofovir..
28/03/202408:00BWGilead and Xilio Announce Exclusive License Agreement for..
22/03/202410:18BWGilead Sciences Announces Completion of Acquisition of..
18/03/202420:29BWCenter for Disease Analysis Foundation Announces First Round..
11/03/202409:24BWGilead Sciences Announces Expiration of Hart-Scott-Rodino..
06/03/202418:30BWBiktarvy® Demonstrates High Rates of Viral Suppression in..
06/03/202412:25BWGilead and Merck Announce Phase 2 Data Showing an..
06/03/202410:00BWGilead and Merus Announce Collaboration to Discover Novel..
05/03/202418:35BWNew Real-World Data Further Support the Use of Veklury®..
05/03/202418:30BWGilead’s Innovative HIV Treatment Research Pipeline Aims to..
27/02/202412:00BWGilead Announces Funding Initiative to Support HIV..
26/02/202418:05BWU.S. FDA Approves Expanded Indication for Gilead’s Biktarvy®..
26/02/202410:30BWGilead to Present Late-Breaking Data and Real-World Evidence..
20/02/202418:05BWGilead Sciences to Present at Upcoming Investor Conferences
09/02/202413:00BWGilead Named One of America’s Most JUST Companies by JUST..
07/02/202407:49IHMARKETNEWSMoody’s Downgrades NYCB to Junk Status, Ford Declares..
06/02/202418:05BWGilead Sciences Announces 2.7 Percent Increase in First..
06/02/202418:02BWGilead Sciences Announces Fourth Quarter and Full Year 2023..
06/02/202408:27IHMARKETNEWSUS Index Futures Mixed, Oil Prices Edge Higher
01/02/202418:31BWTed Love, MD, Joins Gilead Sciences’ Board of Directors
30/01/202410:30BWKite Receives U.S. FDA Approval of Manufacturing Process..
30/01/202408:25IHMARKETNEWSArcus Biosciences Stock Jumps 20% on $320M Gilead..
29/01/202419:00BWGilead and Arcus Announce Amended Collaboration and Equity..
23/01/202418:05BWGilead Sciences to Release Fourth Quarter & Full Year 2023..
22/01/202412:23DJNGilead Down Over 10%, on Pace for Largest Percent Decrease..
22/01/202411:32DJNCorrection to Gilead Says Trodelvy Trial Didn't Meet Primary..
22/01/202411:17DJNGilead Says Trodelvy Lung Cancer Trial Didn't Meet Primary..
22/01/202410:30BWGilead Provides Update on Phase 3 EVOKE-01 Study
21/12/202318:05BWU.S. FDA Approves Label Update for Kite’s Yescarta® CAR..
20/12/202310:45PRNUSRedHill and U.S. Army Announce Opaganib and RHB-107..
19/12/202311:30APSStrong Open For Biotech Following Exclusive Agreement..
19/12/202309:00BWGilead and Compugen Announce Exclusive License Agreement for..
11/12/202323:00BWAnalyses of Kite’s Yescarta® CAR T-Cell Therapy Support..
11/12/202321:30BWNew Analyses Presented at ASH 2023 Support the Potential..
11/12/202319:45BWLong-Term Data for Kite’s Yescarta® CAR T-Cell Therapy..
11/12/202314:00BWGilead Named to Dow Jones Sustainability World Index for..
30/11/202310:30BWGilead’s Leadership in Metastatic Breast Cancer Showcased..
28/11/202317:08DJNFDA Looking Into All Approved CAR T Therapies on Risk of..
28/11/202316:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
24/11/202315:16IHMARKETNEWSCrypto this Friday: Cryptocurrencies Reach New Highs, Kwon’s..
15/11/202310:30DJNArcellx Shares Rise Premarket on Expanded Gilead..
15/11/202308:58DJNGilead Invests Further in Arcellx, Extends Collaboration
15/11/202308:00BWKite and Arcellx Announce Expansion in Strategic Partnership
09/11/202315:26DJNGilead Sciences On Track for Largest Percent Decrease Since..
08/11/202321:13BWGilead Sciences to Present at Upcoming Investor Conferences

Seu Histórico Recente

NASDAQ
GILD
Gilead Sciences
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados